Login/Sign Up
Sorafecare 200mg Tablet
₹2435.4*
MRP ₹2970
18% off
₹2524.5*
MRP ₹2970
15% CB
₹445.5 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Sorafecare 200mg Tablet belongs to the group of medicine called ‘anti-cancer’ that is primarily indicated in the treatment of kidney, liver, and thyroid cancer. Kidney cancer is also known as renal cancer is a disease in which healthy cells of the kidney become malignant (cancerous), grow in an uncontrolled manner, and forms a tumour. Cancer of the liver is known as liver cancer. When cancer occurs in the liver, it destroys healthy cells of the liver and affects the ability of the liver to function normally. Thyroid cancer occurs when cells start multiplying in the thyroid gland and form a tumour. The tumour is a collection of abnormal cells.
Sorafecare 200mg Tablet contains 'Sorafenib' that falls in the category of medicines known as 'kinase inhibitors'. It works by stopping the action of an abnormal protein that causes the multiplication of cancerous cells. In this way, it stops the spread of cancerous cells.
Take Sorafecare 200mg Tablet as prescribed by your doctor. You are suggested to take Sorafecare 200mg Tablet as long as your doctor has prescribed it after checking your medical condition. In some cases, you may experience certain common side-effects such as itching or skin rash, acne, dry skin, vomiting, diarrhoea, and loss of appetite. Most of these side-effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side-effects persistently.
To treat your condition effectually, continue taking Sorafecare 200mg Tablet for as long as your doctor has prescribed. Do not take Sorafecare 200mg Tablet if you are pregnant or planning for pregnancy as Sorafecare 200mg Tablet causes serious birth defects. Sorafecare 200mg Tablet should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant. Elderly people are more sensitive to the medicine so the doctor may adjust the dosage according to the condition. Avoid consuming alcohol along with Sorafecare 200mg Tablet as it could lead to increased dizziness.
Sorafecare 200mg Tablet is a ' tyrosine kinase inhibitor (TKI)', that stops the uncontrolled growth and spread of cancerous cells. Sorafecare 200mg Tablet is effective in treating thyroid, liver and kidney cancer. It acts by stopping the action of the abnormal protein that is responsible for the multiplication of cancerous cells. Whenever a new healthy cell is formed it undergoes a usual process of maturity. Cancerous cells form new cells more quickly so Sorafecare 200mg Tablet targets cancerous cells and block the action of Tyrosine kinases enzymes (responsible for causing cancer). In this way, Sorafecare 200mg Tablet stops the production, spread and growth of cancerous cells in the body.
Sorafecare 200mg Tablet may make you more susceptible to infections; consult your doctor if you develop any signs of infections such as fever, sore throat, breathlessness, jaundice, unexplained bleeding, or bruising. Your doctor may advise you to undergo regular blood tests, kidney and liver tests to monitor your condition. Inform your doctor about your health condition and medicines to rule out any unpleasant side-effects. Before your doctor prescribes you Sorafecare 200mg Tablet, tell them if you have heart problems, high blood pressure, bleeding issues, surgery, or an electrolyte imbalance (like abnormal levels of magnesium, calcium, or potassium in the blood). Sorafecare 200mg Tablet is restricted to use in persons who are sensitive to any of its constituent or have squamous cell lung cancer or already taking carboplatin and paclitaxel.
Drug-Drug Interaction: Sorafecare 200mg Tablet may have interaction with anti-cancer medicine (Sorafenib and Paclitaxel), antibiotics (Neomycin), anti-seizure medicine (carbamazepine, phenytoin), an antacid (Omeprazole).
Drug-Food Interaction: The absorption of Sorafecare 200mg Tablet gets reduced in presence of food. This is why it is suggested to take Sorafecare 200mg Tablet on an empty stomach or 1 or 2 hours after a meal. Additionally, an individual should avoid grapefruit juice as it may increase the amount of drug in the bloodstream.
Drug-Disease Interaction: Do not take Sorafecare 200mg Tablet if you have squamous cell lung cancer.
Cancer: It is a genetic change in which our cells divide uncontrollably and spread into surrounding tissues. There are two types of cancer, namely benign (localized) and metastatic (spread to the whole body). There are more than 100 types of cancer, including blood cancer, lung cancer, breast cancer, etc. Cancer growth can be prevented by chemotherapy (by strong antibiotics), radiation and stem cell therapy. To date, there is no cure for cancer.
Renal cancer: Kidneys help to get rid of waste by filtering blood, regulate fluid balance, and helps in making urine. Kidney cancer occurs when cancerous cells start growing uncontrollably in the kidneys.
Liver cancer: The liver is responsible for making bile that is a substance that helps in digesting fats, nutrients, and other vitamins. When the liver gets infected with cancerous cells, it destroys the liver cells and affects the ability of the liver to work properly.
Thyroid cancer: The thyroid is the gland of the body that produces hormones responsible for the functioning of the body. When thyroid cancer occurs when a person does not remain able to feel the thyroid gland.
Alcohol
Unsafe
You are recommended to avoid alcohol consumption with Sorafecare 200mg Tablet as it may increase the risk of side effects such as dizziness, drowsiness, or difficulty in concentrating.
Pregnancy
Unsafe
Sorafecare 200mg Tablet is restricted to use in pregnancy. A woman needs to have a negative pregnancy test before starting treatment with this medicine. It is better to use effective birth control methods to prevent pregnancy while taking this medicine or for at least 6 months after taking the last dose of Sorafecare 200mg Tablet.
Breast Feeding
Unsafe
Sorafecare 200mg Tablet should not be taken by breastfeeding mothers as it passes into breast milk and may cause a possible risk to the infant.
Driving
Caution
It is not known if Sorafecare 200mg Tablet may affect your driving ability or not.
Liver
Safe if prescribed
Sorafecare 200mg Tablet is safe to take by patients dealing with liver cancer as prescribed by their doctor. The dose may be adjusted by the doctor according to the medical condition of the patient.
Kidney
Safe if prescribed
Sorafecare 200mg Tablet is safe to take by patients dealing with kidney cancer as prescribed by their doctor. The dose may be adjusted by the doctor according to the medical condition of the patient.
Children
Caution
Sorafecare 200mg Tablet is not recommended for children below 18 years as the safety and effectiveness were not established.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes